MTRR

Chr 5

5-methyltetrahydrofolate-homocysteine methyltransferase reductase

Also known as: MSR, cblE

This gene encodes a member of the ferredoxin-NADP(+) reductase (FNR) family of electron transferases. This protein functions in the synthesis of methionine by regenerating methionine synthase to a functional state. Because methionine synthesis requires methyl-group transfer by a folate donor, activity of the encoded enzyme is important for folate metabolism and cellular methylation. Mutations in this gene can cause homocystinuria-megaloblastic anemia, cbl E type. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.98
Clinical SummaryMTRR
🧬
Gene-Disease Validity (ClinGen)
methylcobalamin deficiency type cblE · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
170 unique Pathogenic / Likely Pathogenic· 338 VUS of 1189 total submissions
📖
GeneReview available — MTRR
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.98LOEUF
pLI 0.000
Z-score 1.64
OE 0.71 (0.520.98)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.67Z-score
OE missense 1.10 (1.011.19)
423 obs / 386.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.71 (0.520.98)
00.351.4
Missense OE?1.10 (1.011.19)
00.61.4
Synonymous OE?1.14
01.21.6
LoF obs/exp: 27 / 37.9Missense obs/exp: 423 / 386.2Syn Z: -1.38
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveMTRR-related homocystinuria-megaloblastic anemia, cblE typeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6260th %ile
GOF
0.72top 25%
LOF
0.2776th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

1189 submitted variants in ClinVar

Classification Summary

Pathogenic64
Likely Pathogenic106
VUS338
Likely Benign555
Benign73
Conflicting26
64
Pathogenic
106
Likely Pathogenic
338
VUS
555
Likely Benign
73
Benign
26
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
53
2
9
0
64
Likely Pathogenic
95
7
4
0
106
VUS
4
294
37
3
338
Likely Benign
1
27
206
321
555
Benign
0
5
58
10
73
Conflicting
26
Total1533353143341,162

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

104 pathogenic / likely-pathogenic (of 113) ClinVar copy-number / structural variants overlap MTRR — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MTRR · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →